Back to Search
ROBERT SOIFFER, MD
MD
Medical Oncology Physician
NPI: 1780653261IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
56125(MA)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
Donor lymphocyte infusions for acute myeloid leukaemia.
PMID 18790449·Best Pract Res Clin Haematol·2008
6-review
Immune modulation and chronic graft-versus-host disease.
PMID 18724307·Bone Marrow Transplant·2008
6-review
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
PMID 12947071·J Clin Oncol·2003
3-trial
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
PMID 12359762·Cancer Res·2002
8-other
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
PMID 11181681·J Clin Oncol·2001
3-trial
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
PMID 19539216·Biol Blood Marrow Transplant·2009
3-trial
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
PMID 19509382·JAMA·2009
1-meta
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
PMID 19168788·Blood·2009
8-other
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
PMID 19539208·Biol Blood Marrow Transplant·2009
6-review
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.
PMID 18974373·Blood·2009
3-trial
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
PMID 19660719·Biol Blood Marrow Transplant·2009
8-other
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
PMID 19008459·Blood·2009
3-trial
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
PMID 19159415·Transfusion·2009
3-trial
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
PMID 19203731·Biol Blood Marrow Transplant·2009
8-other
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
PMID 18776081·Blood·2008
8-other
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
PMID 18640576·Biol Blood Marrow Transplant·2008
3-trial
Clinical evaluation of oral chronic graft-versus-host disease.
PMID 18158967·Biol Blood Marrow Transplant·2008
8-other
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
PMID 18756547·Am J Hematol·2008
3-trial
Variation in supportive care practices in hematopoietic cell transplantation.
PMID 18940677·Biol Blood Marrow Transplant·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-4731
Quick Facts
- NPI
- 1780653261
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile